Loading...
Please wait, while we are loading the content...
Similar Documents
Prevalence of plasmid-mediated AmpC β-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum β-lactamase-producing E. coli in Japan.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Matsumura, Yasufumi Yamamoto, Masaki Higuchi, Takeshi Komori, Toshiaki Tsuboi, Fusayuki Hayashi, Akihiko Sugimoto, Yoshihisa Hotta, Gou Matsushima, Aki Nagao, Miki Takakura, Shunji Ichiyama, Satoshi |
| Copyright Year | 2012 |
| Abstract | In 2010, a total of 1327 clinical Escherichia coli isolates from five hospitals in the Kyoto and Shiga regions of Japan were analysed by PCR. The prevalences of plasmid-mediated AmpC β-lactamase (pAmpC)-producers, extended-spectrum β-lactamase (ESBL)-producers and co-producers of pAmpC and ESBL were 1.7%, 9.7% and 0.3%, respectively. Less than one-half of the pAmpC-producers were reported to be resistant to third-generation cephalosporins, cephamycins and β-lactam/β-lactam inhibitors using the old 2009 Clinical and Laboratory Standards Institute (CLSI) breakpoints. CMY-2 was the most prevalent pAmpC type (95%), and CTX-M-14 (38%), CTX-M-15 (26%) and CTX-M-27 (19%) were the most prevalent ESBL types. The worldwide O25b-ST131-B2 clone accounted for 11% of pAmpC-producers and 41% of ESBL-producers. The O25b-ST131-B2 clone was characterised by a CTX-M-27- or CTX-M-15-type ESBL and ciprofloxacin-non-susceptibility with quadruple mutations in the quinolone resistance-determining regions (S83L and D87N in GyrA and S80I and E84V in ParC). A significant proportion of pAmpC-producers and the O25b-ST131-B2 clone were found in Japan by a recent regional surveillance programme. |
| File Format | PDF HTM / HTML |
| DOI | 10.1016/j.ijantimicag.2012.04.013 |
| Alternate Webpage(s) | https://core.ac.uk/download/pdf/39303641.pdf |
| Alternate Webpage(s) | https://repository.kulib.kyoto-u.ac.jp/dspace/bitstream/2433/178036/1/j.ijantimicag.2012.04.013.pdf |
| PubMed reference number | 22743014 |
| Alternate Webpage(s) | https://doi.org/10.1016/j.ijantimicag.2012.04.013 |
| Journal | Medline |
| Volume Number | 40 |
| Issue Number | 2 |
| Journal | International journal of antimicrobial agents |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |